The union between laboratory medication and healthcare excellence is powerful, interjoined and has stood the check of time. This partnership is crucial within the quest for worth-based mostly well being care, increasing the strategic position of the medical laboratory from conventional, transactional fashions to strategic ones that expedite or activate new cascades of care. This paper opinions outcomes and key traits following international recognition of built-in medical care groups for exemplary outcomes of measurably higher well being care. I With the longer term upon us, it’s incumbent upon all healthcare professionals to work collectively, study from others, champion well being outcomes and take part a pledge for healthcare excellence.
n all circumstances, laboratory medication was both a key contributor or chief in predictive threat administration, preventative well being, and integration of medical care by lively synthesis of related knowledge: knowledge which might be too usually below-used, below-acknowledged, and even lacking in conventional fashions of care. Outcomes join multi-disciplinary groups with favorable key efficiency indicators throughout sufferers, payors, clinicians and well being methods, in addition to high illness burdens and unmet gaps of care. Results affirm the probabilities forward with proactive engagement throughout healthcare professionals together with the important and lively position of laboratory medication.
Substance use issues are a extremely prevalent group of continual illnesses with devastating particular person and public well being penalties. Current remedy methods undergo from excessive charges of relapse, or return to drug use, and novel options are desperately wanted. Realize Analyze Engage (RAE) is a digital, mHealth intervention that focusses on actual time, goal detection of excessive-threat occasions (stress and drug craving) to deploy simply-in-time supportive interventions. The current research goals to (1) consider the accuracy and usability of the RAE system and (2) consider the influence of RAE on affected person centered outcomes.
The first section of the research can be an observational trial of N = 50 contributors in outpatient remedy for SUD utilizing the RAE system for 30 days. Accuracy of craving and stress detection algorithms can be evaluated, and usability of RAE can be explored by way of semi-structured interviews with contributors and focus teams with SUD remedy clinicians. The second section of the research can be a randomized managed trial of RAE vs standard care to guage charges of return to make use of, retention in remedy, and high quality of life.
Education within the Time of COVID: At-a-Distance Training in Neuromusculoskeletal Ultrasonography
Point of care ultrasound is necessary to the specialty of bodily medication and rehabilitation (PM&R) to help within the prognosis and remedy of a wide range of neuromusculoskeletal situations generally seen in follow. However, throughout Canada, resident training of sonoanatomy expertise is variable. There stay no requirements by way of how ultrasound is taught as a part of the residency curriculum as set by the Royal College of Physicians and Surgeons of Canada. As such, residents are sometimes required to seek out their very own instructional alternatives. This report describes an alternate method to studying these expertise that was impressed by disruption as a result of coronavirus illness 2019 in first yr residency.
This report explores how a PM&R resident was in a position to develop priceless ultrasound expertise from dwelling utilizing not solely textbooks and movies, but additionally new and novel teleguidance know-how, particularly an ultrasound probe that connects to a clinician’s personal sensible gadgets to show photos. From September to November 2020 we surveyed the chief nursing officers of a consultant pattern of U.S. hospitals relating to organizational actions taken to extend or keep vital care capability through the pandemic.
We calculated weighted proportions of hospitals for every potential motion so as to create estimates throughout your complete inhabitants of U.S. hospitals, accounting for each the sampling technique and non-response. We additionally examined whether or not the forms of actions taken various by the cumulative regional incidence of COVID-19 circumstances.
Structural and Functional Changes Are Related to Cognitive Status in Wilson’s Disease
Patients with Wilson’s illness (WD) undergo from potential reminiscence (PM) impairment, and a few of sufferers develop cognitive impairment. However, little or no is understood about how mind construction and operate modifications impact PM in WD. Here, we employed multimodal neuroimaging knowledge acquired from 22 WD sufferers and 26 wholesome controls (HC) who underwent three-dimensional T1-weighted, diffusion tensor imaging (DTI), and resting state useful magnetic resonance imaging (RS-fMRI). We investigated grey matter (GM) volumes with voxel-based mostly morphometry, DTI metrics utilizing the fiber tractography technique, and RS-fMRI utilizing the seed-based mostly useful connectivity technique.
Compared with HC, WD sufferers confirmed GM quantity reductions within the basal ganglia (BG) and occipital fusiform gyrus, in addition to quantity enhance within the visible affiliation cortex. Moreover, whiter matter (WM) tracks of WD had been broadly impaired in affiliation and limbic fibers. WM tracks in affiliation fibers are important associated to PM in WD sufferers. Relative to HC, WD sufferers confirmed that the visible affiliation cortex functionally connects to the thalamus and hippocampus, which is related to international cognitive operate in sufferers with WD.
 Total Protein - Multiple Sclerosis Disease: Brain: Cerebellum |
|
P1236039Msc |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Multiple Sclerosis Disease: Brain: Frontal Lobe |
|
P1236051Msc |
Biochain |
1 mg |
EUR 542 |
 Frozen Tissue Section - Multiple Sclerosis Disease: Brain: Pons |
|
T1236071Msc |
Biochain |
5 slides |
EUR 523 |
 Total Protein - Multiple Sclerosis Disease: Brain: Parietal Lobe |
|
P1236066Msc |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Multiple Sclerosis Disease: Brain: Temporal Lobe |
|
P1236078Msc |
Biochain |
1 mg |
EUR 542 |
 Paraffin Tissue Section - Multiple Sclerosis Disease: Brain: Pons |
|
T2236071Msc |
Biochain |
5 slides |
EUR 262 |
 Total Protein - Multiple Sclerosis Disease: Brain: Occipital Lobe |
|
P1236062Msc |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Multiple Sclerosis Disease: Brain: Corpus Callosum |
|
P1236045Msc |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Multiple Sclerosis Disease: Brain: Medulla oblongata |
|
P1236057Msc |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Multiple Sclerosis Disease: Brain: Postcentral Gyrus |
|
P1236072Msc |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Multiple Sclerosis Disease: Brain: Precentral Gyrus |
|
P1236073Msc |
Biochain |
1 mg |
EUR 542 |
 Frozen Tissue Section - Multiple Sclerosis Disease: Brain: Amygdala |
|
T1236036Msc |
Biochain |
5 slides |
EUR 523 |
 Frozen Tissue Section - Multiple Sclerosis Disease: Brain: Pituitary |
|
T1236068Msc |
Biochain |
5 slides |
EUR 971 |
 Frozen Tissue Section - Multiple Sclerosis Disease: Brain: Thalamus |
|
T1236079Msc |
Biochain |
5 slides |
EUR 523 |
 Paraffin Tissue Section - Multiple Sclerosis Disease: Brain: Amygdala |
|
T2236036Msc |
Biochain |
5 slides |
EUR 262 |
 Paraffin Tissue Section - Multiple Sclerosis Disease: Brain: Thalamus |
|
T2236079Msc |
Biochain |
5 slides |
EUR 262 |
 Frozen Tissue Section - Multiple Sclerosis Disease: Brain: Cerebellum |
|
T1236039Msc |
Biochain |
5 slides |
EUR 523 |
 Frozen Tissue Section - Multiple Sclerosis Disease: Brain: Hippocampus |
|
T1236052Msc |
Biochain |
5 slides |
EUR 971 |
 Paraffin Tissue Section - Multiple Sclerosis Disease: Brain: Cerebellum |
|
T2236039Msc |
Biochain |
5 slides |
EUR 262 |
 Paraffin Tissue Section - Multiple Sclerosis Disease: Brain: Hippocampus |
|
T2236052Msc |
Biochain |
5 slides |
EUR 834 |
 Frozen Tissue Section - Multiple Sclerosis Disease: Brain: Frontal Lobe |
|
T1236051Msc |
Biochain |
5 slides |
EUR 523 |
 Genomic DNA - Multiple Sclerosis Disease: Brain, from a single donor |
|
D1236035Msc |
Biochain |
50 ug |
EUR 562 |
 Paraffin Tissue Section - Multiple Sclerosis Disease: Brain: Frontal Lobe |
|
T2236051Msc |
Biochain |
5 slides |
EUR 262 |
 Frozen Tissue Section - Multiple Sclerosis Disease: Brain: Occipital Lobe |
|
T1236062Msc |
Biochain |
5 slides |
EUR 523 |
 Frozen Tissue Section - Multiple Sclerosis Disease: Brain: Parietal Lobe |
|
T1236066Msc |
Biochain |
5 slides |
EUR 523 |
 Frozen Tissue Section - Multiple Sclerosis Disease: Brain: Temporal Lobe |
|
T1236078Msc |
Biochain |
5 slides |
EUR 523 |
 Paraffin Tissue Section - Multiple Sclerosis Disease: Brain: Occipital Lobe |
|
T2236062Msc |
Biochain |
5 slides |
EUR 262 |
 Paraffin Tissue Section - Multiple Sclerosis Disease: Brain: Parietal Lobe |
|
T2236066Msc |
Biochain |
5 slides |
EUR 262 |
 Paraffin Tissue Section - Multiple Sclerosis Disease: Brain: Temporal Lobe |
|
T2236078Msc |
Biochain |
5 slides |
EUR 262 |
 Frozen Tissue Section - Multiple Sclerosis Disease: Brain: Corpus Callosum |
|
T1236045Msc |
Biochain |
5 slides |
EUR 523 |
 Frozen Tissue Section - Multiple Sclerosis Disease: Brain: Precentral Gyrus |
|
T1236073Msc |
Biochain |
5 slides |
EUR 523 |
 Paraffin Tissue Section - Multiple Sclerosis Disease: Brain: Corpus Callosum |
|
T2236045Msc |
Biochain |
5 slides |
EUR 262 |
 Paraffin Tissue Section - Multiple Sclerosis Disease: Brain: Precentral Gyrus |
|
T2236073Msc |
Biochain |
5 slides |
EUR 262 |
 Frozen Tissue Section - Multiple Sclerosis Disease: Brain: Medulla oblongata |
|
T1236057Msc |
Biochain |
5 slides |
EUR 523 |
 Frozen Tissue Section - Multiple Sclerosis Disease: Brain: Postcentral Gyrus |
|
T1236072Msc |
Biochain |
5 slides |
EUR 523 |
 Genomic DNA - Multiple Sclerosis Disease: Brain: Pons, from a single donor |
|
D1236071Msc |
Biochain |
50 ug |
EUR 562 |
 Paraffin Tissue Section - Multiple Sclerosis Disease: Brain: Medulla oblongata |
|
T2236057Msc |
Biochain |
5 slides |
EUR 262 |
 Paraffin Tissue Section - Multiple Sclerosis Disease: Brain: Postcentral Gyrus |
|
T2236072Msc |
Biochain |
5 slides |
EUR 262 |
 Genomic DNA - Multiple Sclerosis Disease: Brain: Amygdala, from a single donor |
|
D1236036Msc |
Biochain |
50 ug |
EUR 562 |
 Genomic DNA - Multiple Sclerosis Disease: Brain: Thalamus, from a single donor |
|
D1236079Msc |
Biochain |
50 ug |
EUR 562 |
 Genomic DNA - Multiple Sclerosis Disease: Brain: Cerebellum, from a single donor |
|
D1236039Msc |
Biochain |
50 ug |
EUR 562 |
 Genomic DNA - Multiple Sclerosis Disease: Brain: Frontal Lobe, from a single donor |
|
D1236051Msc |
Biochain |
50 ug |
EUR 562 |
 Genomic DNA - Multiple Sclerosis Disease: Brain: Occipital Lobe, from a single donor |
|
D1236062Msc |
Biochain |
50 ug |
EUR 562 |
 Genomic DNA - Multiple Sclerosis Disease: Brain: Parietal Lobe, from a single donor |
|
D1236066Msc |
Biochain |
50 ug |
EUR 562 |
 Genomic DNA - Multiple Sclerosis Disease: Brain: Temporal Lobe, from a single donor |
|
D1236078Msc |
Biochain |
50 ug |
EUR 562 |
 Genomic DNA - Multiple Sclerosis Disease: Brain: Precentral Gyrus, from a single donor |
|
D1236073Msc |
Biochain |
50 ug |
EUR 562 |
 Genomic DNA - Multiple Sclerosis Disease: Brain: Medulla oblongata, from a single donor |
|
D1236057MSC |
Biochain |
50 ug |
EUR 562 |
 Genomic DNA - Multiple Sclerosis Disease: Brain: Postcentral Gyrus, from a single donor |
|
D1236072Msc |
Biochain |
50 ug |
EUR 562 |
 Human Multiple Sclerosis Leukopak |
|
ABC-TC4294 |
AcceGen |
1 pack |
Ask for price |
|
|
|
Description: Multiple Sclerosis (MS) is a chronic disease that is often progressive. The disease is characterized by damage to the central nervous system. This includes the brain, spinal cord and the optic nerve. MS can cause numbness, severe fatigue, blurred vision and impaired speech and impaired muscular coordination. |
 Single Donor Human Multiple Sclerosis Serum |
|
ISERSMSC |
Innovative research |
each |
EUR 209 |
|
|
|
Description: Single Donor Human Multiple Sclerosis Serum |
 Single Donor Human Multiple Sclerosis Plasma |
|
IPLASMSC |
Innovative research |
each |
EUR 209 |
|
|
|
Description: Single Donor Human Multiple Sclerosis Plasma |
 cDNA - Alzheimer's Disease: Brain |
|
C1236035Alz |
Biochain |
40 reactions |
EUR 802 |
 cDNA - Parkinson's Disease: Brain |
|
C1236035Par |
Biochain |
40 reactions |
EUR 802 |
 cDNA - Alzheimer's Disease: Brain: Pons |
|
C1236071Alz |
Biochain |
40 reactions |
EUR 802 |
 cDNA - Alzheimer's Disease: Brain: Amygdala |
|
C1236036Alz |
Biochain |
40 reactions |
EUR 802 |
 cDNA - Alzheimer's Disease: Brain: Thalamus |
|
C1236079Alz |
Biochain |
40 reactions |
EUR 802 |
 cDNA - Alzheimer's Disease: Brain: Cerebellum |
|
C1236039Alz |
Biochain |
40 reactions |
EUR 802 |
 cDNA - Alzheimer's Disease: Brain: Hippocampus |
|
C1236052Alz |
Biochain |
40 reactions |
EUR 975 |
 cDNA - Parkinson's Disease: Brain: Hippocampus |
|
C1236052Par |
Biochain |
40 reactions |
EUR 975 |
 cDNA - Alzheimer's Disease: Brain: Frontal Lobe |
|
C1236051Alz |
Biochain |
40 reactions |
EUR 802 |
 cDNA - Alzheimer's Disease: Brain: Parietal Lobe |
|
C1236066Alz |
Biochain |
40 reactions |
EUR 802 |
 cDNA - Alzheimer's Disease: Brain: Temporal Lobe |
|
C1236078Alz |
Biochain |
40 reactions |
EUR 802 |
 cDNA - Alzheimer's Disease: Brain: Occipital Lobe |
|
C1236062Alz |
Biochain |
40 reactions |
EUR 802 |
 Multiple types of colon disease with colon tissue array |
|
CO245a |
TissueArray |
each |
EUR 66 |
|
Description: Multiple types of colon disease with colon tissue array, including crohn‘s disease, chronic inflammation of the colonic mucosa, ulcerative colitis, adenocarcinoma, 12 cases/24 cores (core size 1.5mm), replacing CO245 |
 cDNA - Alzheimer's Disease: Brain: Precentral Gyrus |
|
C1236073Alz |
Biochain |
40 reactions |
EUR 802 |
 cDNA - Alzheimer's Disease: Brain: Postcentral Gyrus |
|
C1236072Alz |
Biochain |
40 reactions |
EUR 802 |
 Multiple kidney disease with kidney tissue array (2016/ISUP WHO classification |
|
KD804a |
TissueArray |
each |
EUR 258 |
|
Description: Multiple kidney disease with kidney tissue array (2016/ISUP WHO classification, Grade mean Isup Grade), including pathoogy grade, TNM and clinical stage (reference AJCC 8th version), 75 cases/80 cores, replacing KD804 |
 Multiple diseases of liver tissue array |
|
LV1201b |
TissueArray |
each |
EUR 474 |
|
Description: Multiple diseases of liver tissue array, includin pathology grade, TNM and clinical stage, 118 cases/120 cores, replacing LV1201a |
 Multiple Species Frozen Tissue Array - Brain |
|
T6134035-1 |
Biochain |
1 slide |
EUR 215 |
Multiple Species Frozen Tissue Array - Brain |
|
T6134035-5 |
Biochain |
5 slides |
EUR 782 |
 Multiple Species Tissue Slides - Brain Tissue |
|
10-300-MSTA |
ProSci |
1 pack |
EUR 241.8 |
|
Description: The Multiple Species Tissue Array (MSTA) slides were designed to study protein expression patterns in different cells and tissues from multiple species. Tissue slices from three different species are mounted on each MSTA slide which can then be treated as a single histological slide for H&E staining, immunohistochemistry, or in situ hybridization. This format allows a rapid analysis of protein expression and localization across different species. MSTA slides can also be used to quickly determine the species reactivity of a given antibody. |
 Multiple Species Paraffin Tissue Array - Brain |
|
T8134035-2 |
Biochain |
2 slides |
EUR 252 |
Multiple Species Paraffin Tissue Array - Brain |
|
T8134035-5 |
Biochain |
5 slides |
EUR 505 |
 Total RNA - Alzheimer's Disease: Brain |
|
R1236035Alz-50 |
Biochain |
50 ug |
EUR 460 |
 Multiple sites of normal brain tissue array |
|
BNC17011c |
TissueArray |
each |
EUR 306 |
|
Description: Multiple sites of normal brain tissue array, 26 case/80 cores, replacing BNC17011b |
 cDNA - Human Diabetic Diseased Tissue: Brain |
|
C1236035Dia |
Biochain |
40 reactions |
EUR 802 |
 Total Protein - Alzheimer's Disease: Brain |
|
P1236035Alz |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Parkinson's Disease: Brain |
|
P1236035Par |
Biochain |
1 mg |
EUR 542 |
 - Mouse tuberous sclerosis 1 (cDNA clone MGC:63425 IMAGE:5720967)) Tsc1 (GFP-tagged) - Mouse tuberous sclerosis 1 (cDNA clone MGC:63425 IMAGE:5720967) |
|
MG211709 |
Origene Technologies GmbH |
10 µg |
Ask for price |
 - Mouse tuberous sclerosis 1 (cDNA clone MGC:63425 IMAGE:5720967), (10ug)) Tsc1 (untagged) - Mouse tuberous sclerosis 1 (cDNA clone MGC:63425 IMAGE:5720967), (10ug) |
|
MC223091 |
Origene Technologies GmbH |
10 µg |
Ask for price |
 Total Protein - Alzheimer's Disease: Brain: Pons |
|
P1236071Alz |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Parkinson's Disease: Brain: Pons |
|
P1236071Par |
Biochain |
1 mg |
EUR 542 |
 Frozen Tissue Section - Alzheimer's Disease: Brain |
|
T1236035Alz |
Biochain |
5 slides |
EUR 523 |
 Frozen Tissue Section - Parkinson's Disease: Brain |
|
T1236035Par |
Biochain |
5 slides |
EUR 523 |
 Multiple organ digestive system diseased tissue array with normal tissue as control |
|
BCC000128 |
TissueArray |
each |
EUR 198 |
|
Description: Multiple organ digestive system diseased tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 40 cases/40 cores |
 Total Protein - Alzheimer's Disease: Brain: Amygdala |
|
P1236036Alz |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Parkinson's Disease: Brain: Amygdala |
|
P1236036Par |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Alzheimer's Disease: Brain: Thalamus |
|
P1236079Alz |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Parkinson's Disease: Brain: Thalamus |
|
P1236079Par |
Biochain |
1 mg |
EUR 542 |
 - Mouse tuberous sclerosis 1 (cDNA clone MGC:63425 IMAGE:5720967)) Tsc1 (Myc-DDK-tagged) - Mouse tuberous sclerosis 1 (cDNA clone MGC:63425 IMAGE:5720967) |
|
MR211709 |
Origene Technologies GmbH |
10 µg |
Ask for price |
 Paraffin Tissue Section - Parkinson's Disease: Brain |
|
T2236035Par |
Biochain |
5 slides |
EUR 262 |
 Paraffin Tissue Section - Alzheimers Disease: Brain |
|
T2236035Alz |
Biochain |
5 slides |
EUR 262 |
 Total Protein - Alzheimer's Disease: Brain: Cerebellum |
|
P1236039Alz |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Parkinson's Disease: Brain: Cerebellum |
|
P1236039Par |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Alzheimer's Disease: Brain: Hippocampus |
|
P1236052Alz |
Biochain |
1 mg |
EUR 667 |
 Total Protein - Alzheimer's Disease: Brain: Frontal Lobe |
|
P1236051Alz |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Parkinson's Disease: Brain: Frontal Lobe |
|
P1236051Par |
Biochain |
1 mg |
EUR 542 |
 Frozen Tissue Section - Alzheimer's Disease: Brain: Pons |
|
T1236071Alz |
Biochain |
5 slides |
EUR 523 |
 Frozen Tissue Section - Parkinson's Disease: Brain: Pons |
|
T1236071Par |
Biochain |
5 slides |
EUR 523 |
 Total Protein - Alzheimer's Disease: Brain: Parietal Lobe |
|
P1236066Alz |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Parkinson's Disease: Brain: Parietal Lobe |
|
P1236066Par |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Alzheimer's Disease: Brain: Temporal Lobe |
|
P1236078Alz |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Parkinson's Disease: Brain: Temporal Lobe |
|
P1236078Par |
Biochain |
1 mg |
EUR 542 |
 Paraffin Tissue Section - Parkinson's Disease: Brain: Pons |
|
T2236071Par |
Biochain |
5 slides |
EUR 262 |
 Total Protein - Alzheimer's Disease: Brain: Occipital Lobe |
|
P1236062Alz |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Parkinson's Disease: Brain: Occipital Lobe |
|
P1236062Par |
Biochain |
1 mg |
EUR 542 |
 Paraffin Tissue Section - Alzheimers Disease: Brain: Pons |
|
T2236071Alz |
Biochain |
5 slides |
EUR 262 |
 Total Protein - Alzheimer's Disease: Brain: Corpus Callosum |
|
P1236045Alz |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Parkinson's Disease: Brain: Corpus Callosum |
|
P1236045Par |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Alzheimer's Disease: Brain: Precentral Gyrus |
|
P1236073Alz |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Parkinson's Disease: Brain: Precentral Gyrus |
|
P1236073Par |
Biochain |
1 mg |
EUR 542 |
 Frozen Tissue Section - Alzheimer's Disease: Brain: Amygdala |
|
T1236036Alz |
Biochain |
5 slides |
EUR 523 |
 Frozen Tissue Section - Parkinson's Disease: Brain: Amygdala |
|
T1236036Par |
Biochain |
5 slides |
EUR 523 |
 Frozen Tissue Section - Alzheimer's Disease: Brain: Thalamus |
|
T1236079Alz |
Biochain |
5 slides |
EUR 523 |
 Frozen Tissue Section - Parkinson's Disease: Brain: Thalamus |
|
T1236079Par |
Biochain |
5 slides |
EUR 523 |
 Total Protein - Alzheimer's Disease: Brain: Medulla oblongata |
|
P1236057Alz |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Parkinson's Disease: Brain: Medulla oblongata |
|
P1236057Par |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Alzheimer's Disease: Brain: Postcentral Gyrus |
|
P1236072Alz |
Biochain |
1 mg |
EUR 542 |
 Total Protein - Parkinson's Disease: Brain: Postcentral Gyrus |
|
P1236072Par |
Biochain |
1 mg |
EUR 542 |
 Frozen Tissue Section - Alzheimer's Disease: Brain: Pituitary |
|
T1236068Alz |
Biochain |
5 slides |
EUR 971 |
 Frozen Tissue Section - Parkinson's Disease: Brain: Pituitary |
|
T1236068Par |
Biochain |
5 slides |
EUR 971 |
 Paraffin Tissue Section - Parkinson's Disease: Brain: Amygdala |
|
T2236036Par |
Biochain |
5 slides |
EUR 262 |
 Paraffin Tissue Section - Parkinson's Disease: Brain: Thalamus |
|
T2236079Par |
Biochain |
5 slides |
EUR 262 |
 Frozen Tissue Section - Alzheimer's Disease: Brain: Cerebellum |
|
T1236039Alz |
Biochain |
5 slides |
EUR 523 |
 Frozen Tissue Section - Parkinson's Disease: Brain: Cerebellum |
|
T1236039Par |
Biochain |
5 slides |
EUR 523 |
 Paraffin Tissue Section - Alzheimers Disease: Brain: Amygdala |
|
T2236036Alz |
Biochain |
5 slides |
EUR 262 |
 Paraffin Tissue Section - Alzheimers Disease: Brain: Thalamus |
|
T2236079Alz |
Biochain |
5 slides |
EUR 262 |
 Frozen Tissue Section - Alzheimer's Disease: Brain: Hippocampus |
|
T1236052Alz |
Biochain |
5 slides |
EUR 971 |
 - Mouse tuberous sclerosis 1 (cDNA clone MGC:63425 IMAGE:5720967)) Lenti ORF clone of Tsc1 (mGFP-tagged) - Mouse tuberous sclerosis 1 (cDNA clone MGC:63425 IMAGE:5720967) |
|
MR211709L4 |
Origene Technologies GmbH |
10 µg |
Ask for price |
 Paraffin Tissue Section - Alzheimer's Disease: Brain: Cerebellum |
|
T2236039Alz |
Biochain |
5 slides |
EUR 262 |
 Paraffin Tissue Section - Parkinson's Disease: Brain: Cerebellum |
|
T2236039Par |
Biochain |
5 slides |
EUR 262 |
 Paraffin Tissue Section - Parkinson's Disease: Brain: Hippocampus |
|
T2236052Par |
Biochain |
5 slides |
EUR 834 |
 Paraffin Tissue Section - Alzheimers Disease: Brain: Hippocampus |
|
T2236052Alz |
Biochain |
5 slides |
EUR 834 |
 Tuberous Sclerosis 1 Antibody |
|
20-abx116334 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
|
Tuberous Sclerosis 1 Antibody |
|
abx116334-50l |
Abbexa |
50 µl |
EUR 612.5 |
 Frozen Tissue Section - Alzheimer's Disease: Brain: Frontal Lobe |
|
T1236051Alz |
Biochain |
5 slides |
EUR 523 |
 Frozen Tissue Section - Parkinson's Disease: Brain: Frontal Lobe |
|
T1236051Par |
Biochain |
5 slides |
EUR 523 |
 Genomic DNA - Alzheimer's Disease: Brain, from a single donor |
|
D1236035Alz |
Biochain |
50 ug |
EUR 562 |
 Genomic DNA - Parkinson's Disease: Brain, from a single donor |
|
D1236035Par |
Biochain |
50 ug |
EUR 562 |
 Frozen Tissue Section - Alzheimer's Disease: Brain: Parietal Lobe |
|
T1236066Alz |
Biochain |
5 slides |
EUR 523 |
 Frozen Tissue Section - Parkinson's Disease: Brain: Parietal Lobe |
|
T1236066Par |
Biochain |
5 slides |
EUR 523 |
 Frozen Tissue Section - Alzheimer's Disease: Brain: Temporal Lobe |
|
T1236078Alz |
Biochain |
5 slides |
EUR 523 |
 Frozen Tissue Section - Parkinson's Disease: Brain: Temporal Lobe |
|
T1236078Par |
Biochain |
5 slides |
EUR 523 |
 - Mouse tuberous sclerosis 1 (cDNA clone MGC:63425 IMAGE:5720967)) Lenti ORF clone of Tsc1 (Myc-DDK-tagged) - Mouse tuberous sclerosis 1 (cDNA clone MGC:63425 IMAGE:5720967) |
|
MR211709L3 |
Origene Technologies GmbH |
10 µg |
Ask for price |
 Paraffin Tissue Section - Parkinson's Disease: Brain: Frontal Lobe |
|
T2236051Par |
Biochain |
5 slides |
EUR 262 |
 Frozen Tissue Section - Alzheimer's Disease: Brain: Occipital Lobe |
|
T1236062Alz |
Biochain |
5 slides |
EUR 523 |
 Frozen Tissue Section - Parkinson's Disease: Brain: Occipital Lobe |
|
T1236062Par |
Biochain |
5 slides |
EUR 523 |
 Paraffin Tissue Section - Alzheimers Disease: Brain: Frontal Lobe |
|
T2236051Alz |
Biochain |
5 slides |
EUR 262 |
 Paraffin Tissue Section - Parkinson's Disease: Brain: Parietal Lobe |
|
T2236066Par |
Biochain |
5 slides |
EUR 262 |
 Paraffin Tissue Section - Parkinson's Disease: Brain: Temporal Lobe |
|
T2236078Par |
Biochain |
5 slides |
EUR 262 |
 Frozen Tissue Section - Alzheimer's Disease: Brain: Corpus Callosum |
|
T1236045Alz |
Biochain |
5 slides |
EUR 523 |
 Frozen Tissue Section - Parkinson's Disease: Brain: Corpus Callosum |
|
T1236045Par |
Biochain |
5 slides |
EUR 523 |
 Paraffin Tissue Section - Parkinson's Disease: Brain: Occipital Lobe |
|
T2236062Par |
Biochain |
5 slides |
EUR 262 |
 Paraffin Tissue Section - Alzheimers Disease: Brain: Parietal Lobe |
|
T2236066Alz |
Biochain |
5 slides |
EUR 262 |
 Paraffin Tissue Section - Alzheimers Disease: Brain: Temporal Lobe |
|
T2236078Alz |
Biochain |
5 slides |
EUR 262 |
 Frozen Tissue Section - Alzheimer's Disease: Brain: Precentral Gyrus |
|
T1236073Alz |
Biochain |
5 slides |
EUR 523 |
 Frozen Tissue Section - Parkinson's Disease: Brain: Precentral Gyrus |
|
T1236073Par |
Biochain |
5 slides |
EUR 523 |
 Paraffin Tissue Section - Alzheimers Disease: Brain: Corpus Callosum |
|
T2236045Alz |
Biochain |
5 slides |
EUR 262 |
 Paraffin Tissue Section - Parkinson's Disease: Brain: Corpus Callosum |
|
T2236045Par |
Biochain |
5 slides |
EUR 262 |
 Paraffin Tissue Section - Alzheimers Disease: Brain: Occipital Lobe |
|
T2236062Alz |
Biochain |
5 slides |
EUR 262 |
 Paraffin Tissue Section - Parkinson's Disease: Brain: Precentral Gyrus |
|
T2236073Par |
Biochain |
5 slides |
EUR 262 |
 Frozen Tissue Section - Alzheimer's Disease: Brain: Medulla oblongata |
|
T1236057Alz |
Biochain |
5 slides |
EUR 523 |
 Frozen Tissue Section - Parkinson's Disease: Brain: Medulla oblongata |
|
T1236057Par |
Biochain |
5 slides |
EUR 523 |
 Frozen Tissue Section - Alzheimer's Disease: Brain: Postcentral Gyrus |
|
T1236072Alz |
Biochain |
5 slides |
EUR 523 |
 Frozen Tissue Section - Parkinson's Disease: Brain: Postcentral Gyrus |
|
T1236072Par |
Biochain |
5 slides |
EUR 523 |
 Paraffin Tissue Section - Alzheimer's Disease: Brain: Medulla oblongata |
|
T2236057Alz |
Biochain |
5 slides |
EUR 523 |
 Paraffin Tissue Section - Parkinson's Disease: Brain: Medulla oblongata |
|
T2236057Par |
Biochain |
5 slides |
EUR 262 |
Together, these findings recommended that PM impairment in WD could also be modulated by aberrant WM in affiliation fibers, and that GM quantity modifications within the affiliation cortex has no direct impact on cognitive standing, however not directly have an effect on international cognitive operate by its aberrant useful connectivity (FC) in sufferers with WD. Our findings might present a brand new window to additional research how WD develops into cognitive impairment, and deepen our understanding of the cognitive standing and neuropathology of WD. Our outcomes spotlight the mobile and molecular adjustments throughout early part of NSR, thus offering important insights on regeneration inside Annelida and understanding the neurodegenerative ailments.
